What is the definition of pulmonary hypertension as measured by right heart catheterization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Pulmonary Hypertension by Right Heart Catheterization

Pulmonary hypertension (PH) is defined as a mean pulmonary arterial pressure (mPAP) ≥20 mmHg at rest as measured by right heart catheterization (RHC). 1 This represents a recent update from the previous definition of mPAP ≥25 mmHg that was used for many years.

Hemodynamic Classifications of Pulmonary Hypertension

The complete hemodynamic definition requires additional measurements beyond just the mPAP:

Types of PH Based on Hemodynamic Parameters:

  1. Pre-capillary PH:

    • mPAP >20 mmHg
    • Pulmonary arterial wedge pressure (PAWP) ≤15 mmHg
    • Pulmonary vascular resistance (PVR) >2 Wood Units 1
    • Found in: Groups 1,3,4, and some Group 5 PH
  2. Isolated Post-capillary PH:

    • mPAP >20 mmHg
    • PAWP >15 mmHg
    • PVR ≤2 Wood Units 1
    • Found in: Group 2 and some Group 5 PH
  3. Combined Pre- and Post-capillary PH:

    • mPAP >20 mmHg
    • PAWP >15 mmHg
    • PVR >2 Wood Units 1
    • Found in: Group 2 and some Group 5 PH

Historical Context and Evolution of Definition

  • The original definition of PH (mPAP ≥25 mmHg) was established at the first World Symposium on Pulmonary Hypertension in 1973 2
  • Normal mPAP at rest is 14 ± 3 mmHg, with an upper limit of normal of approximately 20 mmHg 3
  • The 6th World Symposium on Pulmonary Hypertension (2018) revised the definition to mPAP >20 mmHg based on statistical analysis showing this value is 2 standard deviations above the normal mean 2

Clinical Classification Groups

Pulmonary hypertension is classified into five groups based on etiology:

  1. Group 1: Pulmonary Arterial Hypertension (PAH)
  2. Group 2: PH due to Left Heart Disease
  3. Group 3: PH due to Lung Diseases and/or Hypoxemia
  4. Group 4: Chronic Thromboembolic PH (CTEPH)
  5. Group 5: PH with Unclear and/or Multifactorial Mechanisms 3

Importance of Right Heart Catheterization

  • RHC remains the gold standard for diagnosing PH 4, 5
  • Echocardiography can estimate pulmonary pressures but has limitations in accuracy, with correlation to RHC ranging from r=0.57 to r=0.95 3
  • RHC allows for accurate measurement of:
    • Mean pulmonary arterial pressure
    • Pulmonary arterial wedge pressure
    • Pulmonary vascular resistance
    • Cardiac output

Clinical Implications

  • Higher mPAP values correlate with increased mortality risk regardless of PH group 3
  • Mortality increases significantly with elevated pulmonary pressures:
    • 5-year mortality: ~25% for mPAP 19-24 mmHg
    • 5-year mortality: ~40% for mPAP ≥25 mmHg 3

Common Pitfalls in PH Diagnosis

  • Relying solely on echocardiography without confirmatory RHC can lead to misclassification 3
  • Failing to distinguish between pre-capillary and post-capillary PH can result in inappropriate treatment decisions 3
  • Overlooking the possibility of combined pre- and post-capillary PH in patients with left heart disease can lead to inadequate treatment 3

Key Considerations During RHC

  • The pressure transducer zero level should be at the midthoracic line (at the level of the left atrium) for standardized measurements 5
  • Volume or exercise challenge during RHC may help unmask left heart disease in borderline cases, though these approaches require further validation 5
  • In patients with suspected PH, a complete hemodynamic assessment should include measurement of mPAP, PAWP, and calculation of PVR to properly classify the type of PH

References

Research

Definition, classification and diagnosis of pulmonary hypertension.

The European respiratory journal, 2024

Guideline

Pulmonary Hypertension Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Definitions and diagnosis of pulmonary hypertension.

Journal of the American College of Cardiology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.